Zhejiang Medicine Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Medicine has a total shareholder equity of CN¥10.2B and total debt of CN¥808.7M, which brings its debt-to-equity ratio to 7.9%. Its total assets and total liabilities are CN¥12.9B and CN¥2.6B respectively. Zhejiang Medicine's EBIT is CN¥127.4M making its interest coverage ratio 9.3. It has cash and short-term investments of CN¥1.8B.
Key information
7.9%
Debt to equity ratio
CN¥808.72m
Debt
| Interest coverage ratio | 9.3x |
| Cash | CN¥1.82b |
| Equity | CN¥10.24b |
| Total liabilities | CN¥2.63b |
| Total assets | CN¥12.88b |
Recent financial health updates
Recent updates
What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You
Aug 06
Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15
Jul 05The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet
Jun 21Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem
May 02Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet
Mar 29Financial Position Analysis
Short Term Liabilities: 600216's short term assets (CN¥5.7B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: 600216's short term assets (CN¥5.7B) exceed its long term liabilities (CN¥503.3M).
Debt to Equity History and Analysis
Debt Level: 600216 has more cash than its total debt.
Reducing Debt: 600216's debt to equity ratio has reduced from 9.3% to 7.9% over the past 5 years.
Debt Coverage: 600216's debt is well covered by operating cash flow (73.1%).
Interest Coverage: 600216's interest payments on its debt are well covered by EBIT (9.3x coverage).